Cargando…

The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy

BACKGROUND: To investigate a prognostic role of gross tumor volume (GTV) changes on survival outcomes following concurrent chemoradiotherapy (CCRT) in stage III non-small-cell lung cancer (NSCLC) patients. METHODS: We enrolled 191 patients with stage III NSCLC from 2001 to 2009 undergoing definitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Tae Ryool, Moon, Sung Ho, Lim, Yu Jin, Kim, Ja Young, Kim, Yeonjoo, Kim, Tae Hyun, Cho, Kwan Ho, Han, Ji-Youn, Lee, Young Joo, Yun, Tak, Kim, Heung Tae, Lee, Jin Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268851/
https://www.ncbi.nlm.nih.gov/pubmed/25498887
http://dx.doi.org/10.1186/s13014-014-0283-6
_version_ 1782349301981118464
author Koo, Tae Ryool
Moon, Sung Ho
Lim, Yu Jin
Kim, Ja Young
Kim, Yeonjoo
Kim, Tae Hyun
Cho, Kwan Ho
Han, Ji-Youn
Lee, Young Joo
Yun, Tak
Kim, Heung Tae
Lee, Jin Soo
author_facet Koo, Tae Ryool
Moon, Sung Ho
Lim, Yu Jin
Kim, Ja Young
Kim, Yeonjoo
Kim, Tae Hyun
Cho, Kwan Ho
Han, Ji-Youn
Lee, Young Joo
Yun, Tak
Kim, Heung Tae
Lee, Jin Soo
author_sort Koo, Tae Ryool
collection PubMed
description BACKGROUND: To investigate a prognostic role of gross tumor volume (GTV) changes on survival outcomes following concurrent chemoradiotherapy (CCRT) in stage III non-small-cell lung cancer (NSCLC) patients. METHODS: We enrolled 191 patients with stage III NSCLC from 2001 to 2009 undergoing definitive CCRT. The GTV of 157 patients was delineated at the planning CT prior to CCRT and with a follow-up CT 1 month after CCRT. We assessed the volumetric parameters of pre-treatment GTV (GTV(pre)) post-treatment GTV (GTV(post)), and volume reduction ratio of GTV (VRR). The primary endpoint was overall survival (OS) and secondary endpoints were progression-free survival (PFS) and locoregional progression-free survival (LRPFS). The best cut-off value was defined as that which exhibited the maximum difference between the two groups. RESULTS: The median follow-up duration was 52.7 months in surviving patients. Median survival, 3-year OS, PFS and LRPFS rates were 25.5 months, 36.4%, 23.0%, and 45.0%, respectively. The selected cut-off values were 50 cm(3) for GTV(pre), 20 cm(3) for GTV(post), and 50% for VRR. The smaller GTV(pre) and GTV(post) values were associated with better OS (p < 0.001 and p = 0.015) and PFS (p = 0.001 and p = 0.004), respectively, upon univariate analysis. The higher VRR of > 50% was associated with a trend toward poorer OS (p = 0.004) and PFS (p = 0.054). Upon multivariate analysis, smaller GTV(pre) indicated significantly improved OS (p = 0.001), PFS (p = 0.013) and LRPFS (p = 0.002), while smaller GTV(post) was marginally significant for PFS (p = 0.086). Higher VRR was associated with a trend toward poorer OS (p = 0.075). CONCLUSIONS: In patients with stage III NSCLC undergoing definitive CCRT, GTV(pre) was an independent prognostic factor of survival. Notably, improved outcome was not correlated with higher VRR after short-term follow-up with CT alone. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-014-0283-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4268851
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42688512014-12-17 The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy Koo, Tae Ryool Moon, Sung Ho Lim, Yu Jin Kim, Ja Young Kim, Yeonjoo Kim, Tae Hyun Cho, Kwan Ho Han, Ji-Youn Lee, Young Joo Yun, Tak Kim, Heung Tae Lee, Jin Soo Radiat Oncol Research BACKGROUND: To investigate a prognostic role of gross tumor volume (GTV) changes on survival outcomes following concurrent chemoradiotherapy (CCRT) in stage III non-small-cell lung cancer (NSCLC) patients. METHODS: We enrolled 191 patients with stage III NSCLC from 2001 to 2009 undergoing definitive CCRT. The GTV of 157 patients was delineated at the planning CT prior to CCRT and with a follow-up CT 1 month after CCRT. We assessed the volumetric parameters of pre-treatment GTV (GTV(pre)) post-treatment GTV (GTV(post)), and volume reduction ratio of GTV (VRR). The primary endpoint was overall survival (OS) and secondary endpoints were progression-free survival (PFS) and locoregional progression-free survival (LRPFS). The best cut-off value was defined as that which exhibited the maximum difference between the two groups. RESULTS: The median follow-up duration was 52.7 months in surviving patients. Median survival, 3-year OS, PFS and LRPFS rates were 25.5 months, 36.4%, 23.0%, and 45.0%, respectively. The selected cut-off values were 50 cm(3) for GTV(pre), 20 cm(3) for GTV(post), and 50% for VRR. The smaller GTV(pre) and GTV(post) values were associated with better OS (p < 0.001 and p = 0.015) and PFS (p = 0.001 and p = 0.004), respectively, upon univariate analysis. The higher VRR of > 50% was associated with a trend toward poorer OS (p = 0.004) and PFS (p = 0.054). Upon multivariate analysis, smaller GTV(pre) indicated significantly improved OS (p = 0.001), PFS (p = 0.013) and LRPFS (p = 0.002), while smaller GTV(post) was marginally significant for PFS (p = 0.086). Higher VRR was associated with a trend toward poorer OS (p = 0.075). CONCLUSIONS: In patients with stage III NSCLC undergoing definitive CCRT, GTV(pre) was an independent prognostic factor of survival. Notably, improved outcome was not correlated with higher VRR after short-term follow-up with CT alone. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-014-0283-6) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-13 /pmc/articles/PMC4268851/ /pubmed/25498887 http://dx.doi.org/10.1186/s13014-014-0283-6 Text en © Koo et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Koo, Tae Ryool
Moon, Sung Ho
Lim, Yu Jin
Kim, Ja Young
Kim, Yeonjoo
Kim, Tae Hyun
Cho, Kwan Ho
Han, Ji-Youn
Lee, Young Joo
Yun, Tak
Kim, Heung Tae
Lee, Jin Soo
The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
title The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
title_full The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
title_fullStr The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
title_full_unstemmed The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
title_short The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
title_sort effect of tumor volume and its change on survival in stage iii non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268851/
https://www.ncbi.nlm.nih.gov/pubmed/25498887
http://dx.doi.org/10.1186/s13014-014-0283-6
work_keys_str_mv AT kootaeryool theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT moonsungho theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT limyujin theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimjayoung theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimyeonjoo theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimtaehyun theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT chokwanho theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT hanjiyoun theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT leeyoungjoo theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT yuntak theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimheungtae theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT leejinsoo theeffectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kootaeryool effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT moonsungho effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT limyujin effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimjayoung effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimyeonjoo effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimtaehyun effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT chokwanho effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT hanjiyoun effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT leeyoungjoo effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT yuntak effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT kimheungtae effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy
AT leejinsoo effectoftumorvolumeanditschangeonsurvivalinstageiiinonsmallcelllungcancertreatedwithdefinitiveconcurrentchemoradiotherapy